Abstract Trying to surpass host defenses, fungal infections alter the immune response. Components from nonpathogenic fungi present therapeutic anti-inflammatory and immunomodulating activities. This study reveals that proteins present in a Coccidioides posadasii extract provide anti-inflammatory benefit in experimental arthritis. Zymosan was given intra-articularly to rats and mice, and groups were pretreated with C. posadasii extract either per os or intraperitoneally. Controls received the vehicle. Acute hypernociception was evaluated using articular incapacitation and von Frey methods. Cell influx and cytokine levels were assessed in joint exudates. Joint damage was evaluated by histopathology and determination of glycosaminoglycan content of the cartilage. Synovia was evaluated for cell death and inducible nitric oxide synthase (iNOS) expression using TUNEL and immunohistochemistry, respectively. Pretreatment with C. posadasii extract significantly inhibited acute and chronic cell influx, hypernociception, and provoked reduction of glycosaminoglycan loss while reducing chronic synovitis, cell death, and iNOS expression. Reduction/alkylation of C. posadasii extract abrogated these effects. C. posadasii administration did not alter TNF-a, IL-1b, IL-17, and c-interferon levels, whereas IL-10 levels were significantly reduced. Data reveal that a C. posadasii extract reduces iNOS expression that is associated with inhibition of synovial apoptosis and decrease in IL-10 levels released into zymosan-inflamed joints. Characterization of active components excluded charged carbohydrates while pointing to a protein as responsible for these effects. In summary, systemic administration of components from a pathogenic fungus provides anti-inflammatory effects, being species-independent and orally active. Besides adding to understand host response against fungi, the results may lead to therapeutic implications.
Introduction
Several studies have shown the anti-inflammatory and immunomodulating potential of fungal components.
Polysaccharides, proteins, lipids, as well as secondary metabolites, such as triterpenes and phenols, have been described as molecules with immunomodulatory properties [1] . While displaying diverse structure, most fungal polysaccharides belong to b-glucans, which can be chemically modified in order to improve their biological potency. Though the exact mechanism of action of bioactive fungal components is unknown, a common pathway involves the activation of T-lymphocytes and macrophages, thus altering the cytokine repertoire released in the inflammatory response [2] .
Differences in the prevalence of allergic and autoimmune diseases between highly industrialized countries and underdeveloped nations have been associated with a lower prevalence of infections [3] . Less exposure to house dust, high ingestion of industrialized food, diminished breast-feeding, and increased vaccination would decrease stimulation to ''real-life'' germs [4] . In keeping with this assumption, we have demonstrated that the administration of a nematode (Ascaris suum) extract was protective in arthritis models, provoking a decrease in the hypernociceptive response, cell migration, structural damage, and histological changes. These effects were coupled to an alteration in the release of cytokines into the joint exudates [5] .
Attempts to demonstrate anti-inflammatory activity of fungi constituents or released products usually focus on nonpathogenic species. However, immunomodulation is also a strategy employed by pathogens to escape host defenses. The highly virulent fungi Coccidioides immitis/C. posadasii are the etiological agents of coccidioidomycosis, a severe disease that occurs in both humans and animals. Coccidioides species secrete an immunodominant antigen which is able to modulate host immunity in a Th2-biased manner [6] . However, Coccidioides can also secrete endosporulation antigens that stimulate or suppress cell-mediated immunity, depending on the antigen preparation method [7] .
Our group is based in Ceará state (northeast of Brazil), and we have identified and characterized a C. posadasii strain isolated both from the bronchoalveolar lavage of affected patients and from the soil. In our region, the unprotected practice of armadillo (Dasypus novemcinctus and Euphractus sexcinctus) hunting exposes both humans and dogs to large amounts of dispersed Coccidioides spp. arthroconidia [8] .
Zymosan is derived from Saccharomyces cerevisae. When injected into joints, zymosan promotes a severe and chronic arthritis that resembles rheumatoid arthritis [9, 10] . Coupling to Toll-like receptors, Dectin-1 receptors and also mannose-binding lectins are involved in zymosan inflammation [11] , thus opening the possibility of studying both innate and adaptive in vivo immune mechanisms in this arthritis model.
As said above, components from pathogenic fungi and/or their released products may provoke immunomodulatory changes as they encounter the host immune system. The objective of the present study was to investigate whether the systemic administration of an extract from our C. posadasii strain modifies the inflammatory response induced by injection of zymosan into rat and mouse joints.
Materials and Methods

Animals
All animal procedures and experimental protocols were approved by the local ethics committee on animal experimentation at the Faculty of Medicine of the Federal University of Ceará, Brazil (protocol number-90/07). All efforts were made to minimize animal suffering and the number of animals used. The animals were housed in temperature-controlled rooms with 12-h light/dark cycles and free access to water and food. Surgical procedure and animal treatments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication).
Induction of the Zymosan Arthritis (ZYA)
Male Wistar rats (180-200 g) or Swiss mice (25-30 g) (n = 6 per group) from our own animal facilities were used throughout the experiments. Rats or mice received an intra-articular (i.a.) injection of either 1 mg (0.05 ml total volume) or 0.1 mg (0.025 ml total volume) zymosan (Sigma, St. Louis, MO, USA), respectively, dissolved in sterile saline, into their right knee joints. Control groups received only saline i.a. [5] .
Evaluation of Joint Hypernociception
We used the rat knee joint incapacitation test, as described previously, as one of the measures of the inflammatory joint hypernociception [9] . Briefly, after zymosan injection, rats were put to walk on a steel rotary drum (30 cm wide 9 50 cm diameter) that rotates at 3 rpm. Specially designed metal gaiters were wrapped around both hind paws. After placement of the gaiters, the animals were allowed to walk freely for habituation. The right paw was then connected via a simple circuit to a microcomputer data input/output port. The paw elevation time (PET) is the time for which, over a 60-s period, the inflamed hind paw is not in contact with the cylinder. This is directly proportional to the articular incapacitation. The PET was measured at baseline and then hourly, until killing, at 6 h. Results (s/1 min) are reported as the maximal PET that occurs between 3 and 4 h after injection of the zymosan.
For evaluation of joint hypernociception by the electronic von Frey method, rats were placed in acrylic cages (12 9 10 9 17 cm high) with a wire grid floor 20-30 min before testing. During this adaptation period, the paws were poked two to three times. Before right paw stimulation, the animals were quiet, without exploratory movements or defecation and not resting on their paws. In these experiments, we used a pressure-meter which consisted of a handheld force transducer fitted with a 0.5-mm 2 polypropylene tip (Electronic von Frey anesthesiometer, Insight Equipamentos Científicos Ltda., Ribeirão Preto, SP, Brasil). The investigator, blinded to the treatment protocol (see below), was trained to apply the polypropylene tip perpendicularly to the central area of the hind paw with a gradual increase in pressure. The test consisted of poking the right hind paw to provoke a flexion reflex followed by a clear flinch response after paw withdrawal. In the electronic pressure-meter test, the intensity of the stimulus was automatically recorded when the paw was withdrawn. The stimulation of the paw was repeated until the animal presented three similar measurements. Results are expressed as the mean of the mechanical threshold (g) after three stimulations (pokes) at each time-point [12] .
Collection of Synovial Exudates and Analysis of Cell Influx, Cytokines, and Nitric Oxide (NO) Levels in the Joint Exudates At 6 h (acute phase) or 7 days (chronic phase) after injection of the zymosan, the animals were anesthetized with chloral hydrate (400 mg/kg intraperitoneal-i.p.), killed by cervical dislocation, and exsanguinated. The synovial cavity of the knee joints was then washed twice with 0.2 ml (rats) or 0.05 ml (mice) of saline containing 10 mM EDTA. The synovial exudates were collected by aspiration, and total cell counts were performed using a Neubauer chamber. After centrifugation (500 g/10 min), the supernatants were stored at -80°C and used for the determination of cytokine release. The concentrations of tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-10, IL-17, and c-interferon (c-IFN) were measured in the synovial exudates obtained 6 h after zymosan injection in rats and mice, using a commercially available ELISA kit (R&D Systems, São Paulo, SP, Brasil).
Synovial Histopathology
After killing, the synovia was excised, fixed in 10 % buffered formaldehyde, and processed for routine hematoxylin-eosin (HE) staining. Semiquantitative histopathological grading was performed by one independent pathologist blinded to group allocation according to the presence of edema, synovial proliferation, cell infiltration, proliferation of blood vessels, fibrosis, and stage of the disease, ranging from 0 to 3 (0, absent; 1, mild; 2, moderate; 3, severe) for each parameter. The maximal total score was 18. Results are expressed as the median (variation) value for each group of six animals [5] .
Immunohistochemistry for Inducible Nitric Oxide Synthase (iNOS) Detection
The synovial samples were used to assess the expression of the iNOS enzyme, using a commercially available rabbit anti-NOS2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Briefly, after deparaffinization, the tissues were incubated with hydrogen peroxide and washed. After incubation in citrate buffer, specimens were subjected to slight heating in a microwave oven. After overnight unspecific blocking with rabbit serum, the samples were incubated with the rabbit anti-NOS2 antibody (diluted 1:200 in PBS plus 1 % of BSA, 2 h). After rinsing, the sections were incubated with a secondary biotinylated anti-rabbit IgG antibody. The reaction product was detected using Envision TM System-HRP (AEC) complex (DAKO, Carpinteria, CA, USA), and the color of the reaction was developed with diaminobenzidine tetrahydrochloride (DAKO, Carpinteria, CA, USA). The slides were counterstained with Mayer's hematoxylin. The intensity of the staining was analyzed under light microscopy, by counting the number of positive cells/10 randomly selected fields, and was scored as follows: 0 = no staining; 1 = lowintensity staining in \50 % of the cells; 2 = intense staining in \50 % of the cells; and 3 = intense staining in [50 % of the cells. Results are expressed as the median (variation) value for each group of six animals.
Evaluation of Cell Death In Vivo
We used the ApopTag Plus Peroxidase In Situ Detection Kit (Serologicals Corp., Norcross, GA, USA) for TUNEL (terminal deoxynucleotidyltransferasemediated dUTP-biotin nick end labeling) in order to detect apoptosis in the synovial specimens. The ApopTag Plus Peroxidase In Situ Detection Kit distinguishes apoptosis from necrosis by specifically detecting DNA cleavage and chromatin condensation associated with apoptosis. However, cells that morphologically appear to be necrotic may stain lightly. In addition, DNA fragmentation can be absent or incomplete in induced apoptosis. Therefore, the results were presented as TUNEL-positive cells [13] . Paraffin-embedded synovial sample sections were hydrated and incubated with 20 lg/ml of proteinase K (Sigma, Brasil) for 15 min at room temperature (RT). Endogenous peroxidase was blocked by treatment with 3 % (wt/vol) hydrogen peroxide in PBS for 5 min at RT. Slides were then washed with PBS, and sections were incubated in a humidified chamber at 37°C for 1 h with TdT buffer containing TdT enzyme and reaction buffer. Samples were then incubated for 10 min at RT with a stop/wash buffer and then incubated in a humidified chamber for 30 min with anti-digoxigenin-peroxidase conjugate at RT. Following washing several times in PBS, the slides were covered with peroxidase substrate to develop color and then washed in three changes of distilled H 2 O and counterstained in 0.5 % (vol/vol) methyl green for 10 min at RT. 
Assessment of Articular Cartilage Damage
The glycosaminoglycan (GAG) content of the articular cartilage was determined as follows: The cartilage of the distal femoral extremities was excised. The samples were weighed after drying overnight at 80°C. The material was subjected to proteolysis using Prolav 750 (Prozyn, São Paulo, SP, Brasil) and further precipitation in absolute ethanol, followed by dilution in distilled water. This material was separated on a 0.6 % agarose gel electrophoresis. After staining with 0.1 % toluidine blue, quantitation was made by densitometry (525 nm). For comparison, standards of chondroitin 4-sulfate and chondroitin 6-sulfate were subjected to the same protocol. Data were expressed as lg GAG/mg of dried cartilage [14] .
Preparation of the C. posadasii Extract
The antigenic extract was prepared with a C. posadasii strain (CEMM 01-6-085) isolated in Ceará State (Brazil) from a clinical source. The isolate belongs to the Specialized Medical Mycology Center (CEMM) culture collection and was identified by mycological analysis. In brief, cultures of the mycelia phase were grown in a 2 % glucose/1 % yeast extract broth for approximately 30 days at 30°C. Each culture was killed with 0.2 g thimerosal/l (ethylmercurithiosalicylic acid sodium salt; Synth, São Paulo, SP, Brasil), and the supernatant was collected by paper filtration. Protein was precipitated with solid ammonium sulfate (Sigma-Aldrich, São Paulo, SP, Brasil) until the filtrate reached 90 % saturation. The mixture was kept at 4°C for 24 h, and then the precipitated proteins were recovered by centrifugation and dialysed exhaustively against a 109 volume of distilled water using a dialysis membrane with a 10 kD molecular mass cutoff [15] . As a separate step to denature proteins present in the extract, a sample of the dialysate was subjected to a reducing process, by incubating with 45 mM dithiothreitol (DTT) for 1 h, at 56°C, followed by alkylation with 100 mM iodoacetamide for 3 h, at room temperature. The dialysates were stored at -20°C until use [16] .
Characterization of Components in the C. posadasii Extract
As an initial attempt to identify proteins present in the C. posadasii extract, it was run on a silverstained polyacrylamide gel (12 %) electrophoresis in glycine buffer. The presence of charged carbohydrates was investigated by separating the C. posadasii extract in a 6 % (wt/vol) polyacrylamide gel electrophoresis in diaminopropane acetate buffer (50 mM [pH 9.0]). This gel was stained with a 0.1 % (wt/vol) toluidine blue solution. For comparison, high-and low-molecular-weight standards (Bio-rad, São Paulo, SP, Brasil) as well as standard chondroitin 4-sulfate and chondroitin 6-sulfate (Sigma, St. Louis, MO, USA) were subjected to the same protocols, as indicated.
Treatments
Test groups received the C. posadasii extract, dissolved in sterile saline, either i.p. or per os (p.o.) 30 min prior to the i.a. injection of zymosan. The amount of extract to be administered was based on protein content, using the Bradford method [17] . After obtaining a dose-response curve (10-100 lg) in mice or rats, groups of animals received the reduced/ alkylated extract in order to test for the activity of protein components, as follows: To reduce disulfide bonds, 100 mM DTT was added to a final concentration of 10 mM in the protein solutions and incubated for 1 h at 56°C in the dark. Free thiol (-SH) groups were subsequently alkylated with iodoacetamide (50 mM final concentration) for 45 min at room temperature. In order to rule out the effect of an irrelevant protein, a group of animals subjected to ZYA received 100 lg bovine serum albumin (BSA), either i.p. or p.o.
Statistical Analysis
Data are presented as mean ± standard error of the mean (SEM) or medians (range), as appropriate. Differences between means and medians were analyzed using one-way analysis of variance followed by Tukey's test or Kruskal-Wallis test, respectively. p \ 0.05 was considered significant.
Results
Coccidioides posadasii Extract Reduced Cell
Influx in acute and chronic ZYA in Rats and Mice
Administration of zymosan into the joints of rats and mice induced cell influx into the joint cavity that was most intense at 6 h, with predominance ([85 %) of polymorphonuclear cells. At 7 days, cell counts in joint exudates were less pronounced, with mononuclear cells being predominant [9] . Figure 1 shows that administration of the C. posadasii extract, either i.p. or p.o., significantly and dose dependently reduced cell influx in the acute and chronic phase of ZYA in both species, as compared to vehicle-treated animals. Moreover, the isolated administration of the C. posadasii extract to naive animals did not alter cell counts. In order to exclude endotoxin contamination, we should stress that both the extract and BSA solution were prepared under sterile conditions and filtered before administration. Additionally, incubation of C. posadasii extract with polymyxin did not modify its effects on acute cell influx (data not shown). Also, the fact that the extract was effective after being given orally per se excludes the possibility of endotoxin contamination as responsible for the effects observed.
In an attempt to demonstrate that a protein component is responsible for the effect observed with the C. posadasii extract, we subjected the extract to a reducing/alkylating process, a step that denatures proteins containing disulfide bridges. As shown in Fig. 1e , administration of the extract following this protein-denaturing process led to a significant reduction in the effect observed with the crude extract. The administration of a 100 lg BSA solution given as an irrelevant protein either p.o. or i.p. did not alter hypernociception or cell influx (data not shown).
Coccidioides posadasii Extract Reduced Hypernociception in ZYA in Rats
Rats subjected to ZYA displayed an intense hypernociceptive response measured using both the articular incapacitation test and the von Frey methods, as shown in Fig. 2a, b , respectively. Similar to what happened with the cell influx, pretreatment of the animals with the C. posadasii extract, regardless of using i.p. and p.o. routes, significantly reduced the acute hypernociception measured with the articular incapacitation test (Fig. 2a) as well as the persistent chronic hypernociceptive response measured from 3 h until 7 days after injection of the zymosan, using the electronic von Frey method (Fig. 2b) , as compared to vehicle-treated animals. Administration of the C. posadasii extract to naive animals did not alter the hypernociceptive response. 
Coccidioides posadasii Extract Effect on Cartilage Damage in ZYA in Rats
The GAG loss in the articular cartilage measured after 7 days of ZYA can be used as an index of structural joint damage in this model. As compared to naive animals, those that received i.a. zymosan displayed a significant reduction in the GAG content [18] . The administration of the C. posadasii extract provoked a partial, though not reaching statistical significance, reversion of the decrease in the GAG content of the cartilage, as compared to vehicle-treated rats, as follows: naive (44.1 ± 7.05 lg/mg); zymosan (31.2 ± 4.92 lg/mg); and C. posadasii ? zymosan (36.7 ± 3.65 lg/mg). Figure 3 illustrates the histopathological appearance of the synovia of mice subjected to ZYA. It can be seen that pretreatment with the C. posadasii extract (Fig. 3c ) Fig. 2 Effect of the parenteral and oral administration of the C.p. extract on the hypernociception in acute (a) or chronic (b) ZYA in rats. a Rats received the C.p. extract or saline (-) either i.p. or p.o. 30 min prior to 1 mg zymosan. Naive rats received saline i.a. Articular incapacitation was measured hourly over 4 h as the increase in PET using the rat knee joint incapacitation test. Results show mean ± SEM of maximal PET between 3 and 4 h of arthritis. n = 6 animals for each group; ! p \ 0.05 compared to naive rats; *p \ 0.05 compared to control (-) rats. b Rats received the C.p. extract or saline (Zy) i.p. 30 min prior to 1 mg zymosan. Naive rats received saline i.a. The flexion-elicited hypernociception withdrawal threshold (g) was evaluated 3, 5 h, and then daily for 7 days after injection of the zymosan. Results show mean ± SEM of nociceptive threshold; n = 6 animals for each group. *p \ 0.05 compared to control (Zy) rats Mycopathologia (2013) 175:193-206 199 almost completely abrogated the synovitis, provoking a marked decrease in the number of infiltrating cells. A synovial sample of a naive mouse is shown for comparison (Fig. 3a) , as well as the sample from an animal subjected to ZYA treated with the vehicle (Fig. 3b) . The administration of the extract also provoked a decrease in synovial cell hyperplasia, neovascular formation, and fibrosis, as shown in Table 1 .
Coccidioides posadasii Extract Reduced the Histopathology Changes of the Synovia in ZYA in Mice
Coccidioides posadasii Extract Reduces Cell Death in the Synovial Layer
Injection of the zymosan significantly increased the number of TUNEL-positive cells (apoptosis and possibly necrosis) as compared to synovial samples from naive animals, which display no staining (Fig. 4) . The number of TUNEL-positive cells was significantly reduced in the samples from the animals that were treated with the C. posadasii extract, as compared to those that received zymosan and the vehicle (cell death is indicated by the brown staining of the cells detected by the TUNEL method).
Coccidioides posadasii Extract Decreases iNOS Activation in the Synovia
Figure 5a-c illustrates photomicrographs of the immunostaining for iNOS activity in the synovia obtained from negative control (5a), naive (5b), zymosan (5c), and 30 lg C.p. ? zymosan (5d) groups. There is a clear and significant (p \ 0.02) reduction in the immunostaining in the samples of animals that received C.p. extract (median score = 1; range 0-2), as compared to those that received zymosan and the vehicle (median score = 2; range 1-3).
Effect of the C. posadasii Extract on the Release of Inflammatory Mediators in acute ZYA
The C. posadasii extract did not alter the release of IL-1b, TNF-a, c-IFN, and IL-17 into the joints of mice subjected to ZYA (Fig. 6a, b, c, d , respectively). The levels of these cytokines were measured at 6 h of arthritis in the joint exudates. On the other hand, Fig. 6e shows that IL-10 joint levels, also measured at 6 h, were significantly reduced, as compared to salinetreated animals. Analogous to what was observed in mice, the C. posadasii extract did not alter the release of IL-1b and TNF-a into the joints of rats subjected to ZYA (Fig. 7a, b, respectively) . The levels of these cytokines were measured at 6 h of arthritis in the joint exudates. On the other hand, Fig. 7c shows that IL-10 joint levels, also measured at 6 h, were significantly reduced, as compared to saline-treated animals.
Preliminary Characterization of Components in the C. posadasii Extract Figure 8a , b illustrates a silver-stained 12 % polyacrylamide electrophoresis gel of the C. posadasii extract to identify proteins and a toluidine blue-stained 6 % agarose gel electrophoresis aimed to identify charged carbohydrates, respectively. Analysis of the proteins run on lane 2 was done using E-Capt TM (12.7 version for Windows) software aiming to estimate the molecular weight comparing to the Bio-rad TM standards run on parallel. Twelve bands were identified, ranging from 4 to 172 kD. There is a wide range of both low-and high-molecular-weight proteins shown in the silver-stained gel. Additional purification is needed in order to try to identify active components implicated in the protective effects of the C. posadasii extract. On the other hand, the absence of charged carbohydrates, as shown on lane 3 of Fig. 8b , virtually excludes such components as responsible for the results achieved.
Discussion
The present study demonstrates that a C. posadasii extract, administered either parenterally or per os, has dose-dependent in vivo anti-inflammatory properties by inhibiting joint hypernociception and acute neutrophil migration into the inflamed joints as well as the increase in mononuclear cell counts in the chronic phase-7 days-of zymosan arthritis. At histopathology, neovascular formation, fibrosis, lymphocyte, and mononuclear cell proliferation together with hyperplasia of the synovial lining cells were also significantly reduced by the pre-administration of a single dose of the C. posadasii extract. In keeping with the pathogenetic relevance of the present results, joint damage, assessed by measuring the glycosaminoglycan content of the cartilage, was reduced, though not significantly, in animals that received the fungal extract, as compared to vehicle-treated rats. The demonstration of efficacy in different species, dose dependence, and activity in the acute and chronic phases both orally and parenterally clearly adds to the bulk of important anti-inflammatory and immunomodulating properties described with other fungal products [19] .
Synovial resident cells, macrophages, and neutrophils present in the inflamed synovia are main sources of reactive oxygen species during synovitis. Zymosaninduced arthritis is characterized by an acute influx of polymorphonuclear cells that is more prominent at 6 h, while mononuclear cells (mostly lymphocytes and monocytes) predominate after the first day. At 7 days, there is an intense chronic synovitis with synovial hyperplasia and mononuclear cell proliferation, together with angiogenesis, fibrosis, and, eventually, giant cell formation [9] . As a result, inflammatory mediators, particularly cytokines, can be directly assessed in the joint exudates, thus allowing the study of mechanisms involved in synovitis development.
We have demonstrated that neutrophils contribute to the formation of both nitric oxide (NO) and peroxynitrite in zymosan arthritis [20] . In the present study, administration of the C. posadasii extract markedly decreased the expression of iNOS in the inflamed synovia. Release of NO by macrophages has been proposed to be a protective mechanism linked to innate immunity that prevents disease development in subjects exposed to other fungi, for example, Paracoccidioides brasiliensis [21] . However, we are not aware of in vivo data showing that fungi components given systemically alter NO release either locally or systemically. Mice injected intraperitoneally with viable C. immitis display increased urine nitrate levels, thus reflecting augmented NO production following coccidiomycosis development [22] . On the other hand, macrophages stimulated with zymosan particles in vitro show a decreased release of NO when in the presence of P. brasiliensis-derived peptides [21] . Our in vivo data suggest that administration of the C. posadasii extract provoked a decrease in iNOS activation, predominantly in synoviocytes, thereby reducing the generation of reactive oxygen species in the joint.
Joint damage, pain, as well as cell infiltration observed in zymosan arthritis are closely related to the increase in the production of proinflammatory mediators such as TNF-a and IL-1b locally [23, 24] . Other cytokines, including IL-10 and IL-17, have been described to participate in the pathogenesis of fungi reactions as well as in arthritis. While the former may display anti-inflammatory properties [25] , the latter has been implicated in the acute hypernociception in Fig. 4 Representative illustration of the effect of C.p. extract on cell death in the zymosan-inflamed synovial detected by TUNEL method. Mice received 30 lg of C.p. extract (c) or saline (b) given i.p. 30 min prior to 0.1 mg zymosan i.a. Naive mice (a) received saline i.a. All animals were killed at 6 h. The results are expressed as the average number of TUNEL-positive cells. p \ 0.05 when compared to zymosan experimental arthritis, as we have shown recently [26] . Measuring the level of these mediators in the synovial fluid rather than in serum or using ex vivo strategies may more appropriately reflect what is happening inside the joint. Our results showed no difference between the group that received the C. posadasii extract and control groups regarding the release of IL-1b, TNF-a, c -IFN, and IL-17 into the joints. We have to stress that although TNF-a joint levels significantly rise in rats at 6 h of zymosan arthritis, the levels of this cytokine are not significantly elevated in mice joints, possibly due to species variation [5] . Given that the administration of the C. posadasii extract did not alter c-IFN, IL-1b, TNF-a, and IL-17 joint levels, our data argue against a participation of Th1 cytokines as well as these proinflammatory cytokines to explain the in vivo anti-inflammatory and immunomodulatory effects of the C. posadasii extract in zymosan arthritis.
Interestingly, our results show that IL-10 levels in the joints were significantly reduced in both rats and mice that received the C. posadasii extract. It was shown that experimental coccidiomycosis in susceptible mice is associated with increased levels of IL-10 in the lungs. The same group later reported that in vitro stimulation of macrophages isolated from a C. immitissusceptible mouse strain led to increased production of IL-10 and reduced levels of TNF-a, as compared to a resistant coccidiomycosis mouse strain. These effects were reduced by an antibody against Dectin-1 [22] . In summary, those data led to a proposal that genetic ablation of the Dectin-1 gene severely impairs IL-10 production [27] . To our knowledge, there are no reports showing alteration of cytokine release following systemic administration of Coccidioides sp. components. Our data add to these previous in vitro results since we measured in vivo production directly released into inflamed joints. Thus, we speculate that protein components of our C. posadasii extract, either isolated or linked to fungal polysaccharides, interfered with zymosan coupling to Dectin-1 receptors, thereby leading to decreased IL-10 production. Our present results also revealed that apoptosis, predominantly of synovial lining cells, was markedly reduced in the group treated with the C. posadasii extract. NO is able to promote apoptosis of various cell types, including macrophages, neutrophils, and synoviocytes [28] . It has also been shown that stimulation of monocytederived cells with zymosan in the presence of apoptotic cells enhances IL-10 production [29] . As a possible mechanism to explain the reduced IL-10 levels promoted by the C. posadasii extract, we propose that the blockade of iNOS activation leads to a reduction in NO levels locally that in turn decreases the number of apoptotic cells, thus reducing IL-10 production by macrophagelike synoviocytes in the zymosan-inflamed joints. Results represent mean ± SEM, measured at 6 h (n = 6 animals for each group); ! p \ 0.05 compared to naive rats; *p \ 0.05 compared to control (-) rats
We are pursuing studies trying to isolate active component(s) present in the C. posadasii extract. Since the extract acted after being given orally, the possibility of lipopolysaccharide contamination to explain our data can be disregarded. The reducing/ alkylating step applied to our C. posadasii extract abrogated the anti-inflammatory/immunomodulating effect, thus indicating that a protein or a polypeptide containing disulfide bridges is responsible for its biological activity. We cannot exclude the possibility that isolated polysaccharides or protein/polypeptide components attached to them are responsible for the anti-inflammatory results achieved. Notwithstanding the complexity of defining a specific active component, we have to stress that our data are an in vivo original demonstration that either isolated proteins or associated with other fungi components, obtained from a dimorphic pathogenic species, are capable of modifying remote in vivo inflammatory responses. Further characterization of the specific active components in this extract that we are currently undergoing may unravel mechanistic effects that can be of relevance to understand the host response against fungal components.
